Cargando…
A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer
We wanted to evaluate the prognostic value of common histopathological variables in a large cohort of patients with cancer in the mobile tongue as such information can be important for treatment stratification of the individual patient, especially for patients with low-stage disease. In addition, we...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683438/ https://www.ncbi.nlm.nih.gov/pubmed/32607687 http://dx.doi.org/10.1007/s00428-020-02875-9 |
_version_ | 1783612877604651008 |
---|---|
author | Bjerkli, Inger-Heidi Hadler-Olsen, Elin Nginamau, Elisabeth Sivy Laurvik, Helene Søland, Tine M. Costea, Daniela Elena Uhlin-Hansen, Lars Steigen, Sonja E. |
author_facet | Bjerkli, Inger-Heidi Hadler-Olsen, Elin Nginamau, Elisabeth Sivy Laurvik, Helene Søland, Tine M. Costea, Daniela Elena Uhlin-Hansen, Lars Steigen, Sonja E. |
author_sort | Bjerkli, Inger-Heidi |
collection | PubMed |
description | We wanted to evaluate the prognostic value of common histopathological variables in a large cohort of patients with cancer in the mobile tongue as such information can be important for treatment stratification of the individual patient, especially for patients with low-stage disease. In addition, we wanted to investigate whether an alternative scoring model with fewer options would compromise the prognostic value. One hundred fifty patients with oral tongue squamous cell carcinomas that were treated in curative intent and with available HE-stained tumor sections were included. We reclassified all tumors and performed univariate and multivariate survival analyses of histopathological and clinical variables. For the complete cohort, lymph node status, grade of differentiation, perineural infiltration, and lymphocytic infiltration were independent prognosticators. In the low-stage disease group, independent prognostic factors were tumor size, grade of differentiation, and lymphocytic infiltrate. For patients with low-stage disease, a histo-score combining the scores for tumor differentiation and lymphocytic infiltrate identified a group of patients with particularly low survival, as patients with moderately or poorly differentiated tumors and little lymphocytic infiltrate had a less favorable 5-year survival outcome than patients in the high-stage disease group. This study shows that a histo-score combining tumor differentiation and lymphocytic infiltration should be given special consideration in treatment planning. Our results also illustrate that many variables can be scored with fewer options than previously suggested to increase their reproducibility, and still maintain their prognostic value. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00428-020-02875-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7683438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-76834382020-11-30 A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer Bjerkli, Inger-Heidi Hadler-Olsen, Elin Nginamau, Elisabeth Sivy Laurvik, Helene Søland, Tine M. Costea, Daniela Elena Uhlin-Hansen, Lars Steigen, Sonja E. Virchows Arch Original Article We wanted to evaluate the prognostic value of common histopathological variables in a large cohort of patients with cancer in the mobile tongue as such information can be important for treatment stratification of the individual patient, especially for patients with low-stage disease. In addition, we wanted to investigate whether an alternative scoring model with fewer options would compromise the prognostic value. One hundred fifty patients with oral tongue squamous cell carcinomas that were treated in curative intent and with available HE-stained tumor sections were included. We reclassified all tumors and performed univariate and multivariate survival analyses of histopathological and clinical variables. For the complete cohort, lymph node status, grade of differentiation, perineural infiltration, and lymphocytic infiltration were independent prognosticators. In the low-stage disease group, independent prognostic factors were tumor size, grade of differentiation, and lymphocytic infiltrate. For patients with low-stage disease, a histo-score combining the scores for tumor differentiation and lymphocytic infiltrate identified a group of patients with particularly low survival, as patients with moderately or poorly differentiated tumors and little lymphocytic infiltrate had a less favorable 5-year survival outcome than patients in the high-stage disease group. This study shows that a histo-score combining tumor differentiation and lymphocytic infiltration should be given special consideration in treatment planning. Our results also illustrate that many variables can be scored with fewer options than previously suggested to increase their reproducibility, and still maintain their prognostic value. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00428-020-02875-9) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-06-30 2020 /pmc/articles/PMC7683438/ /pubmed/32607687 http://dx.doi.org/10.1007/s00428-020-02875-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Bjerkli, Inger-Heidi Hadler-Olsen, Elin Nginamau, Elisabeth Sivy Laurvik, Helene Søland, Tine M. Costea, Daniela Elena Uhlin-Hansen, Lars Steigen, Sonja E. A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer |
title | A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer |
title_full | A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer |
title_fullStr | A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer |
title_full_unstemmed | A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer |
title_short | A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer |
title_sort | combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683438/ https://www.ncbi.nlm.nih.gov/pubmed/32607687 http://dx.doi.org/10.1007/s00428-020-02875-9 |
work_keys_str_mv | AT bjerkliingerheidi acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT hadlerolsenelin acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT nginamauelisabethsivy acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT laurvikhelene acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT sølandtinem acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT costeadanielaelena acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT uhlinhansenlars acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT steigensonjae acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT bjerkliingerheidi combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT hadlerolsenelin combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT nginamauelisabethsivy combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT laurvikhelene combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT sølandtinem combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT costeadanielaelena combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT uhlinhansenlars combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer AT steigensonjae combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer |